<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01263522</url>
  </required_header>
  <id_info>
    <org_study_id>SAusE2011</org_study_id>
    <nct_id>NCT01263522</nct_id>
  </id_info>
  <brief_title>Optimization of Preventive Effects of Physical Training</brief_title>
  <acronym>SAusE</acronym>
  <official_title>Optimization of Preventive Effects of Physical Training &quot;Saarländische Ausdauer-Etappe (SAusE)&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saarland University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saarland University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Health-promoting effects of physical exercise are well-investigated especially for endurance
      activities. However, for different individuals, positive effects have different sizes, even
      non-responders are observed. Other forms of training, such as strength training and interval
      training, are less well investigated. Therefore, a comparative longitudinal training study is
      warranted to examine differences of preventive effects (outcome measures: ergometric
      descriptors of physical performance, established risk factors and prognostic factors for
      cardiovascular diseases) of continuous endurance training, interval training and strength
      endurance training.

      In a second stage, the observed non-responders will perform a different type of training
      (cross-over). It is expected, that besides a comparative general efficacy evaluation of the
      three training types, improved recommendations for optimized individualization of training
      parameters can be formulated.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2010</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>VO2 max</measure>
    <time_frame>6 months</time_frame>
    <description>determined during treadmill testing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>resting heart rate</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>resting blood pressure</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood lipid profile</measure>
    <time_frame>6 months</time_frame>
    <description>ratio: total cholesterol/HDL-cholesterol</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">266</enrollment>
  <condition>Primary Prevention, Cardiovascular Risk Factor Management, Size of Response to Training</condition>
  <arm_group>
    <arm_group_label>Endurance training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>interval training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>strength endurance training</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>different training programs</intervention_name>
    <description>two different endurance programs and one strength endurance program</description>
    <arm_group_label>Endurance training</arm_group_label>
    <arm_group_label>interval training</arm_group_label>
    <arm_group_label>strength endurance training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>control condition</intervention_name>
    <description>unchanged lifestyle</description>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  untrained

          -  healthy

          -  non-smoking

        Exclusion Criteria:

          -  Contraindications for physical activity

          -  BMI &gt; 30 kg/m2

          -  resting blood pressure &gt; 160/100 mmHg

          -  diabetes

          -  total cholesterol &gt; 300 mg/dl

          -  maximal oxygen uptake &gt; 50 ml/min/kg for men and &gt; 45 ml/min/kg for women respectively

          -  other complaints or diseases that might interfere with exercise training
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Institute of Sports and Preventive Medicine, Saarland University, Bldg. B 8-2, 66123 Saarbrücken</name>
      <address>
        <city>Saarbrücken</city>
        <state>Saarland</state>
        <zip>66123</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2010</study_first_submitted>
  <study_first_submitted_qc>December 17, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2010</study_first_posted>
  <last_update_submitted>May 4, 2018</last_update_submitted>
  <last_update_submitted_qc>May 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>primary prevention</keyword>
  <keyword>endurance</keyword>
  <keyword>cardiovascular risk factors</keyword>
  <keyword>training</keyword>
  <keyword>exercise</keyword>
  <keyword>non-responder</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

